The U.S. Food and Drug Administration and a trade group that represents large compound pharmacies have resolved a long-running dispute over the use of bulk ingredients, clearing the way for some compounded medicines to become available more quickly.
At issue has been the approach taken by the agency to approve the use of certain bulk substances, or active ingredients, which could be used to make compounded medicines. A federal law that went into effect in 2013 requires the FDA to identify ingredients needed to satisfy an unmet “clinical need” and to include those on a list for use by large compounding pharmacies.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED"ingredients" - Google News
October 12, 2022 at 11:01PM
https://ift.tt/o0cKmx8
FDA, compound pharmacies settle dispute over a key list for ingredients - STAT
"ingredients" - Google News
https://ift.tt/f73ebgR
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update
Bagikan Berita Ini
0 Response to "FDA, compound pharmacies settle dispute over a key list for ingredients - STAT"
Post a Comment